Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (201-210 of 436) with videos related to

Pageof 44
Sort By:
Brain Research|March 1, 1985
Intertectal neuronal plasticity in Xenopus laevis: persistence despite catecholamine depletionS B Udin, M J Keating, E A Dawes, et al.
Investigational New Drugs|January 1, 1985
Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitorA M Maddox, M J Keating, K E McCredie, et al.
Cancer Treatment Reports|May 1, 1979
Clinical studies with rubidazoneR S Benjamin, M J Keating, K D Swenerton, et al.
Cancer Treatment Reports|April 1, 1983
Phase II trial of mitoxantrone in refractory acute leukemiaE H Estey, M J Keating, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1981
Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adultsB S Yap, K B McCredie, M J Keating, et al.
Bulletin Du Cancer|January 1, 1980
Knowledge acquisition from historical data: application to breast cancer patientsE A Gehan, T L Smith, A U Buzdar, et al.
Cancer Treatment Reports|May 1, 1981
Phase I--II study of 3-deazauridine in adults with acute leukemiaB S Yap, K B McCredie, M J Keating, et al.
Leukemia|September 30, 2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsR-H Xu, H Pelicano, H Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The characteristics and outcome of patients with late relapse acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Cancer Research|December 1, 1977
A phase 1 and 2 trial of rubidazone in patients with acute leukemiaR S Benjamin, M J Keating, K B McCredie, et al.
Pageof 44

Showing results (201-210 of 436) with videos related to

Sort By:
Pageof 44
Brain Research|March 1, 1985
Intertectal neuronal plasticity in Xenopus laevis: persistence despite catecholamine depletionS B Udin, M J Keating, E A Dawes, et al.
Investigational New Drugs|January 1, 1985
Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitorA M Maddox, M J Keating, K E McCredie, et al.
Cancer Treatment Reports|May 1, 1979
Clinical studies with rubidazoneR S Benjamin, M J Keating, K D Swenerton, et al.
Cancer Treatment Reports|April 1, 1983
Phase II trial of mitoxantrone in refractory acute leukemiaE H Estey, M J Keating, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1981
Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adultsB S Yap, K B McCredie, M J Keating, et al.
Bulletin Du Cancer|January 1, 1980
Knowledge acquisition from historical data: application to breast cancer patientsE A Gehan, T L Smith, A U Buzdar, et al.
Cancer Treatment Reports|May 1, 1981
Phase I--II study of 3-deazauridine in adults with acute leukemiaB S Yap, K B McCredie, M J Keating, et al.
Leukemia|September 30, 2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsR-H Xu, H Pelicano, H Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The characteristics and outcome of patients with late relapse acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Cancer Research|December 1, 1977
A phase 1 and 2 trial of rubidazone in patients with acute leukemiaR S Benjamin, M J Keating, K B McCredie, et al.
Pageof 44